Patent · US Expired

Cyclic peptide and imaging compound compositions and uses for targeted imaging and therapy

US7371364B2 · kind B2 · utility

3Cited by
0References
39Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 13, 2004
Grant dateMay 13, 2008
Priority date
Expiry dateFeb 26, 2025

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K14/8146
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates to novel cyclic peptides that may be conjugated with imaging agents, including novel imaging agents. Specifically, it includes c(KRGDf; SEQ ID NO. 3) NIR imaging compositions and novel cyclic HWGFTL (SEQ ID NO. 5) polypeptides which may be used inter alia in NIR, MRI and nuclear imaging as well as therapy. Additionally, the invention includes novel imaging agents, such as TS-ICG derivatives. The invention also relates to methods of making and using such compounds. Such uses include both pre-operative and intraoperative detection of tumor cells and treatment monitoring.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.